Single-cell analysis identifies Ifi27l2a as a gene regulator of microglial inflammation in the context of aging and stroke in mice
- PMID: 39953063
- PMCID: PMC11828888
- DOI: 10.1038/s41467-025-56847-1
Single-cell analysis identifies Ifi27l2a as a gene regulator of microglial inflammation in the context of aging and stroke in mice
Abstract
Inflammation is a significant driver of ischemic stroke pathology in the brain. To identify potential regulators of inflammation, we performed single-cell RNA sequencing (scRNA-seq) of young and aged mouse brains following stroke and found that interferon alpha-inducible protein 27 like 2 A (Ifi27l2a) was significantly up-regulated, particularly in microglia of aged brain. Ifi27l2a is induced by interferons for viral host defense and has been linked with pro-inflammatory cellular mechanisms. However, its potential role in neurodegeneration is unknown. Using a combination of cell culture, experimental stroke models in mice, and human autopsy brain samples, we demonstrated that induction of Ifi27l2a occurs in microglia in response to aging, ischemic stroke, and pro-inflammatory molecules. We further showed that induction of Ifi27l2a in microglia was sufficient to stimulate mitochondrial ROS production and promote a pro-inflammatory phenotype. Lastly, using an ischemic stroke model, we demonstrated that hemizygous deletion of Ifi27l2a (Ifi27l2a+/- mice) reduced gliosis (microgliosis and astrogliosis), acute and chronic brain injury, and motor function deficits. Together, these findings identify Ifi27l2a as a critical neuroinflammatory mediator in ischemic stroke and provide support for the therapeutic strategy of disrupting Ifi27l2a to attenuate inflammation in the post-stroke brain.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures
Update of
-
Single-cell analysis identifies Ifi27l2a as a novel gene regulator of microglial inflammation in the context of aging and stroke.Res Sq [Preprint]. 2023 Feb 15:rs.3.rs-2557290. doi: 10.21203/rs.3.rs-2557290/v1. Res Sq. 2023. Update in: Nat Commun. 2025 Feb 14;16(1):1639. doi: 10.1038/s41467-025-56847-1. PMID: 36824976 Free PMC article. Updated. Preprint.
References
MeSH terms
Substances
Grants and funding
- R21 AG072488/AG/NIA NIH HHS/United States
- R56NS120709/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- R56 NS120709/NS/NINDS NIH HHS/United States
- R01AG081942/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- R56AG084130/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- R56 AG084130/AG/NIA NIH HHS/United States
- R01HL159159/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- R21AG072488/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- R01NS133324/U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- S10 OD030336/OD/NIH HHS/United States
- R01 HL159159/HL/NHLBI NIH HHS/United States
- R01 AG081942/AG/NIA NIH HHS/United States
- R01 NS133324/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
